166 related articles for article (PubMed ID: 12495937)
21. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
22. Serine proteinase requirement for the extra-cellular metabolism of pulmonary surfactant.
Gross NJ; Schultz RM
Biochim Biophys Acta; 1990 May; 1044(2):222-30. PubMed ID: 2344440
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological activity of potent and selective inhibitors of blood coagulation factor Xa.
Willardsen JA; Dudley DA; Cody WL; Chi L; McClanahan TB; Mertz TE; Potoczak RE; Narasimhan LS; Holland DR; Rapundalo ST; Edmunds JJ
J Med Chem; 2004 Jul; 47(16):4089-99. PubMed ID: 15267248
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.
Fevig JM; Pinto DJ; Han Q; Quan ML; Pruitt JR; Jacobson IC; Galemmo RA; Wang S; Orwat MJ; Bostrom LL; Knabb RM; Wong PC; Lam PYS ; Wexler RR
Bioorg Med Chem Lett; 2001 Mar; 11(5):641-5. PubMed ID: 11266160
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human alpha-, beta- and gamma-thrombin by mono-, bis-, tris- and tetra-benzamidine structures: thermodynamic study.
Ascenzi P; Fruttero R; Amiconi G; Pugliese L; Bolognesi M; Coletta M; Onesti S; Guarneri M; Menegatti E
J Enzyme Inhib; 1992; 6(2):131-9. PubMed ID: 1284429
[TBL] [Abstract][Full Text] [Related]
26. Resistance of different surfactant preparations to inactivation by meconium.
Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B
Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417
[TBL] [Abstract][Full Text] [Related]
27. Are factor Xa inhibitors superior to thrombin inhibitors in anticoagulation?
Stürzebecher J; Stürzebecher U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):152-6. PubMed ID: 2459011
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure.
Selwood T; McCaslin DR; Schechter NM
Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of four human serine proteases by substituted benzamidines.
Andrews JM; Roman DP; Bing DH
J Med Chem; 1978 Dec; 21(12):1202-7. PubMed ID: 152812
[TBL] [Abstract][Full Text] [Related]
30. Trypsin- and SLIGRL-induced vascular relaxation and the inhibition by benzamidine derivatives.
Glusa E; Saft A; Prasa D; Stürzebecher J
Thromb Haemost; 1997 Nov; 78(5):1399-403. PubMed ID: 9408026
[TBL] [Abstract][Full Text] [Related]
31. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase.
Enyedy IJ; Lee SL; Kuo AH; Dickson RB; Lin CY; Wang S
J Med Chem; 2001 Apr; 44(9):1349-55. PubMed ID: 11311057
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive study on the mechanism of inhibition of serine proteases by benzamidines based on quantitative structure-activity relationship studies.
Gupta SP; Handa A; Shewade DG
Arzneimittelforschung; 1987 Jan; 37(1):47-50. PubMed ID: 2952126
[TBL] [Abstract][Full Text] [Related]
33. Oxyanion-mediated inhibition of serine proteases.
Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
[TBL] [Abstract][Full Text] [Related]
35. Compositional and functional changes of pulmonary surfactant in a guinea-pig model of chronic asthma.
Cheng G; Ueda T; Sugiyama K; Toda M; Fukuda T
Respir Med; 2001 Mar; 95(3):180-6. PubMed ID: 11266234
[TBL] [Abstract][Full Text] [Related]
36. Aromatic tetra-amidines: antiproteolytic and antiesterolytic activities towards serine proteinases involved in blood coagulation and clot lysis.
Ferroni R; Menegatti E; Orlandini P; Guarneri M; Taddeo U; Bolognesi M; Ascenzi P; Bertollini A; Amiconi G
Farmaco Sci; 1986 Jun; 41(6):464-70. PubMed ID: 3527742
[TBL] [Abstract][Full Text] [Related]
37. Effects of lung injury on pulmonary surfactant aggregate conversion in vivo and in vitro.
Veldhuizen RA; Ito Y; Marcou J; Yao LJ; McCaig L; Lewis JF
Am J Physiol; 1997 May; 272(5 Pt 1):L872-8. PubMed ID: 9176251
[TBL] [Abstract][Full Text] [Related]
38. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.
Mander A; Langton-Hewer S; Bernhard W; Warner JO; Postle AD
Am J Respir Cell Mol Biol; 2002 Dec; 27(6):714-21. PubMed ID: 12444031
[TBL] [Abstract][Full Text] [Related]
39. Characterization and isolation of a trypsin-like serine protease from a long-term culture cytolytic T cell line and its expression by functionally distinct T cells.
Kramer MD; Binninger L; Schirrmacher V; Moll H; Prester M; Nerz G; Simon MM
J Immunol; 1986 Jun; 136(12):4644-51. PubMed ID: 2423597
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by 4',6-diamidino-2-phenylindole, 6-amidinoindole and benzamidine: a comparative thermodynamic and X-ray structural study.
Casale E; Collyer C; Ascenzi P; Balliano G; Milla P; Viola F; Fasano M; Menegatti E; Bolognesi M
Biophys Chem; 1995 Mar; 54(1):75-81. PubMed ID: 7703351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
